Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Bohui Innovation Biotechnology is a leading Chinese healthcare company specializing in the development and commercialization of in vitro diagnostic (IVD) systems and biopharmaceutical products. The company is a market leader in trace element clinical testing, utilizing advanced atomic absorption spectrometry and mass spectrometry platforms for pediatric and maternal health. Bohui has pioneered the use of microfluidic chip technology for molecular diagnostics, enabling rapid and automated detection of pathogens such as HPV and respiratory viruses. Additionally, through its strategic acquisitions of companies like Tonrol and Da'an Pharmaceutical, Bohui has established a significant presence in the blood products sector, producing essential therapeutics like human albumin and immunoglobulin. Headquartered in Beijing and listed on the Shenzhen Stock Exchange, the company integrates diagnostic precision with therapeutic solutions to serve global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bohui Tech.